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Objectives: To determine the risk of perinatal transmission of hepatitis B virus (HBV) in Jordan.
Methods: Plasma samples from 1000 pregnant Jordanian women were screened by ELISA for HBV markers
(HBsAg, HBeAg, anti-HBe, anti-HBc and anti-HBs).
Results: HBsAg and HBeAg were detected in 4.3% and 0.1% of the pregnant women, respectively. The overall
prevalence of antibodies was 6%, 11.1% and 7.5% for anti-HBe, anti-HBc and anti-HBs, respectively. Women
wereassignedtofourgroupsaccordingtotheserologicalpatternsofHBVmarkers:susceptible(85.9%),withacute
infection (2.9%), with chronic infection (1.4%) and previously infected (9.8%). Most women were at the third
trimester of pregnancy, therefore women with acute and chronic hepatitis at this gestational age were at risk of
transmitting HBV infection to their newborns. Women who belonged to the low socio-economic class were
at higher risk of HBV infection.
Conclusions: Based on the results, we recommend screening women for HBV during pregnancy in order to
identify HBV carriers. All newborns born to carriers should be vaccinated immediately after birth, both passively
and actively. Also vaccination of HBV seronegative pregnant women is recommended.
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Perinatal transmission of hepatitis B virus (HBV) is
animportantrouteofinfection.Itoccursmainly in
infants due to exposure to infected blood and
genital secretions during delivery1,2 and to in utero
passage of HBV DNA3. In the absence of
immunoprophylaxis, perinatal transmission occurs
in 10–20% of women who are seropositive for
hepatitis B surface antigen (HBsAg) and up to 90%
in women who are seropositive for both HBsAg
andhepatitisBe antigen(HBeAg)4,5.Newbornsto
HBsAg-positive mothers who do not become
infected at birth remain at high risk of infection
until the age of 5–6 years4. However, newbornsof
HBeAg positive women are carriers and at risk
of long-term complications of hepatitis B
infection including cirrhosis and hepatocellular
carcinoma6,7. They may not eliminate the virus
despite passive–active immunization8.
To prevent HBV infection, a universal strategy
hasbeen adoptedby manycountries9. Thestrategy
is based on screening pregnant women for HBV
markers and providing passive and active immuni-
zation to newborns of potentially infectious
mothers.
In Jordan, hepatitis B vaccine has been inte-
grated into the current childhood immunization
program since 1995. But screening of pregnant or
childbearing women for HBV markers is not a
routine test. Therefore, the need to know the
prevalence of HBV in pregnancy and the risk of
perinatal transmission of HBV is vital in the plan-
ning of preventive measures. For this reason, the
present study has been conducted to: (1) provide
information on the prevalence of HBV markers
among pregnant women in Jordan; (2) examine
the relationship between HBV seropositivity and
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Clinical study 127risk factors; and (3) evaluate the possibility of
maternal transmission in view of seroprevalence
of HBV markers in pregnant women.
SUBJECTS AND METHODS
Subjects
One thousand pregnant Jordanian women aged
15–44 years, attending the antenatal clinic in
Amman and Al-Salt, were randomly studied. The
implications of chronic HBV infection and the
risks of transmission of the virus to the infant were
explained to the participating women, and their
consent to take part in the study was obtained.
Each woman completed a questionnaire that
included: age, history of hepatitis, blood trans-
fusion,hemodialysis, surgery anddentalprocedure
and socioeconomic status, which was determined
based on family size and annual family income.
Serology
Five milliliters of blood was taken from each
woman. The plasma was separated, aliquoted and
stored at -20°C untilassayed. Plasma samples were
tested for antibody against hepatitis B core antigen
(anti-HBc), HBsAg and its antibody (anti-HBs)
and HBeAg and its antibody (anti-HBe) by
commercially available ELISA kits (DiaSorin,
Italy).
Biochemical tests
The levels of alanine transaminase (ALT) and
aspartate aminotransferase (AST) in each plasma
sample were measured by spectrophotometer
using commercially available ALT and AST
testing kits (Menagent, Italy) according to the
manufacturer’s instructions.
Statistical analysis
The data were analyzed statistically using the
Chi-square test. P values of less than 0.05 were
considered significant.
RESULTS
Prevalence of HBV serological markers
Asshownin Table1, HBsAg was foundin 4.3% of
plasma samples, indicating acute or chronic infec-
tion with HBV. Only one woman was found
positive for HBeAg, indicating also acute or
chronic infection. The overall prevalence of anti-
bodies was 6%, 11.1% and 7.5% for anti-HBe,
anti-HBc and anti-HBs, respectively. Presence of
these antibodies indicates chronic infection or
recovery from acute infection. There was no sig-
nificant difference among age groups with respect
totheprevalenceofHBV antigensandantibodies.
Liver function tests
All women with the serological markers shown in
Table 1 had transaminases within the normal
range, indicating the absence of liver damage.
Hepatitis B status
The women were divided into four groups (I–IV)
according to the serological patterns of HBV
markers (Table 2). Eight hundred and fifty-nine
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Number of positive women
HBsAg HBeAg anti-HBe anti-HBc anti-HBs
Age n (%) n (%) n (%) n (%) n (%)
15–24
25–34
34–44
16
15
12
1.6
1.5
1.2
1
0
0
0.1
0
0
15
30
15
1.5
3
1.5
25
56
30
2.5
5.6
3
15
37
23
1.5
3.7
2.3
Total 43 4.3 1 0.1 60 6 111 11.1 75 7.5
Table 1 Seroprevalence of HBV markers in pregnant Jordanian women by agewomen were susceptible to HBV infection due to
the absence of all serological HBV markers
(group I). A total of 141 women showed HBV
serological markers; forty-three of them were
HBsAg-positive and98were HBsAg-negative. Of
the 43 HBsAg-positive women, 28 were at the
incubationperiod (groupIIa), onewas at theacute
phase of infection (group IIb) and 14 had chronic
infection (group IIIa,b). Of the 98 HBsAg-
negative women, 41 were at recovery phase or
convalescence with typical HBV antibody
markers (group IVa), while 57 were at this phase
with loss of one or two of the antibodies
(group IVb–d).
Prevalence of HBV infection according to
socio-economic status
Data presented in Table 3 clearly demonstrate that
most women (685) have a low socio-economic
status, while 312 and 3 women have mid and high
status, respectively. HBV infection is correlated
inversely with socio-economic status. All women
of higher status were susceptible to HBV and none
had hepatitis at the time of or prior to the study. In
contrast, 276 and 580 women of mid and low
status, respectively, were susceptible (group I) and
the rest had hepatitis at the time of the study
(groups II and III) or had recovered from hepatitis
(group IV).
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HBV serological markers Total
Group Maternal status HBsAg HBeAg anti-HBe anti-HBc anti-HBs n (%)
I
II
III
IV
a
b
a
b
a
b
c
d
Susceptible
Acute infection (incubation period)
Acute infection (acute phase)
Chronic infection
Chronic infection
Recovery or convalescence
Recovery with loss of anti-HBs
Recovery with loss of anti-HBe
Recovery with loss of anti-HBs and
anti-HBe
–
+
+
+
+
–
–
–
–
–
–
+
–
–
–
–
–
–
–
–
–
+
+
+
+
–
–
–
–
+
–
+
+
+
+
+
–
–
–
–
–
+
–
+
–
859
28
1
2
12
41
5
32
20
85.9
2.8
0.1
0.2
1.2
4.1
0.5
3.2
2
+, positive result; –, negative result
Table 2 Hepatitis B status of Jordanian pregnant women
Group I
(n = 859)
Group II
(n = 29)
Group III
(n = 14)
Group IV
(n = 98)
Total
(n = 1000)
Characteristics n (%) n (%) n (%) n (%) n (%)
Economic status
High
Mid
Low
Employed
Unemployed
3
276
580
60
799
0.3
32.2
67.5
7
93
0
7
22
5
24
0
24.1
75.9
0.5
2.4
0
2
12
0
14
0
14.3
85.7
0
1.4
0
27
71
5
93
0
27.5
72.5
5.1
94.9
3
312
685
70
930
0.3
31.2
68.5
7
93
Table 3 Prevalence of HBV infection in pregnant Jordanian women, stratified by socio-economic statusHBV infection is significantly higher in women
of lower socio-economic status than in those of
mid status (p < 0.01). Most HBsAg-positive
women were of low status. Twenty-two HBsAg-
positive women with acute hepatitis (group II)
were of low socio-economic status compared with
seven of mid status. Twelve HBsAg-positive
women with chronic hepatitis (group III) were of
low status while two were of mid status. Similarly,
71 women who had hepatitis prior to the study
(group IV) were of low status while 27 were of
mid status.
The majority of women (930) were unem-
ployed; there was a higher prevalence of HBV
infection among unemployed than employed
women (Table 3). Sixty employed and 799
unemployed women, respectively, were suscept-
ible to HBV infection (group I). Most HBsAg-
positivewomen(24)withacutehepatitis(groupII)
and all HBsAg-positive women with chronic
hepatitis (group III) were unemployed.
Prevalence of HBV infection
in relation to risk factors
Data presented in Table 4 is based on the answers
in the questionnaire. Only two women reported a
history of hepatitis, 117 had a blood transfusion,
five had hemodialysis, 776 had a dental procedure
and 417 had undergone surgery. There were no
significant differences between groups I–IV with
respect to these risk factors (p = 0.5–0.9).
DISCUSSION
Maternal screening and treatment of newborns by
passive and active immunization can control
perinatal transmission of HBV. Screening of
pregnant Jordanian women revealed that 4.3%
were HBsAg positive with acute or chronic hepa-
titis. There was no significant difference in the
prevalence of HBsAg in different age groups.
Similar results were reported by other investi-
gators10. Inotherpartsoftheworld,theprevalence
of HBsAg in pregnant women has been reported
as 0.1–39.7%10–13.
One out of the 1000 pregnant women was
found positive for HBeAg. Higher prevalence has
been reported in pregnant women: 4.6% in South
Africa14, 6.2% in Turkey13 and 43% in Taiwan10.
Presence ofHBsAg orbothHBsAg and HBeAg
inpregnantJordanianwomenindicateshighrisk of
maternal–fetal transmission. Their newborns
should receive hepatitis B immunoglobulin
(HBIG) immediately after birth and vaccination
within 12 hours of birth.
Screening of Jordanian women for HBV anti-
bodies revealed that 6%, 11.1% and 7.5% were
positive for anti-HBe, anti-HBc and anti-HBs,
respectively. Presence of anti-HBe indicates a risk
of perinatal transmission in those with chronic
infection. Anti-HBs was found in most anti-HBc
mothers who had hepatitis indicating that those
women are immunized and there is no risk of
maternal transmission. Anti-HBc was detected in
most women with chronic infection and in all
women who had hepatitis. Lower prevalence of
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Group
(n = 859)
Group II
(n = 29)
Group II
(n = 14)
Group IV
(n = 98)
Total
(n = 1000)
Characteristics n (%) n (%) n (%) n (%) n (%)
History of hepatitis
History of blood transfusion
History of hemodialysis
Dental procedure
Surgery
0
99
4
658
350
0
11.5
0.5
76.6
40.7
0
3
0
22
10
0
10.3
0
75.9
34.5
1
3
0
13
8
7.1
21.4
0
92.9
57.1
2
12
1
83
49
2
12.3
1
84.7
50
2
117
5
776
417
0.2
11.7
0.5
77.6
41.7
Table 4 Prevalence of HBV infection in pregnant Jordanian women in relation to risk factorsanti-HBc was reported in Swiss (3.3%), Spanish
(3.7%) and Portuguese (5.4%) women12. Higher
prevalence was reported in ex-Yugoslavian
(18.6%), Turkish (29.9%) and African (39.7%)
women12. Of special interest is the group of
20 anti-HBc positive women with ‘isolated
anti-HBc’.Theycouldeitherhave recovered from
acute HBV infection and cleared HBsAg but not
yet developedanti-HBs, orinfectedforalongtime
and lost both anti-HBe and anti-HBs. In the
former case, newborns – especially for mothers in
the third trimester – could be at risk of in utero
infection which might occur some time before
delivery, as reported in pregnant Swiss women12.
To eliminate the risk of perinatal transmission in
Jordan, we also recommend active and passive
immunization of newborns of this group of
women.
In the present study, 85.9% of women are sus-
ceptible to HBV infection and need vaccination
and follow-up during pregnancy. Their infants
require only vaccination15 according to the
immunization program in Jordan.
Most women, including those who have acute
and chronic infection, are of low socioeconomic
status. Intrafamilial transmission might occur due
to sharing of facilities and overcrowding (median
number of family members before marriage = 10;
median number of children = 4). There was no
statistical difference among the groups of women
according to the risk factors (Table 4). We con-
cluded that blood transfusion, hemodialysis,
surgery and dental procedure are not major routes
of HBV infection in the population studied.
In conclusion, we reinforce the potential
value of the vaccination program targeted at
Jordanian children in early life along with passive
immunizationofnewbornsofHBsAg-positive and
HBeAg-positive mothers. Seroprevalence surveys
of HBV infection in children must be carried out
todeterminetheeffectivenessoftheHBVvaccina-
tionprograminJordan.Wealso recommendHBV
screening during pregnancy and possibly vaccina-
tion of pregnant women.
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